- Home
- IPA
as 11-15-2024 4:00pm EST
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, Australia and others. The majority of its revenue is derived from United States of America.
| Founded: | 1983 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 18.9M | IPO Year: | 2017 |
| Target Price: | $6.00 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.77 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.35 - $2.60 | Next Earning Date: | 12-12-2024 |
| Revenue: | $17,441,886 | Revenue Growth: | 11.21% |
| Revenue Growth (this year): | 4.33% | Revenue Growth (next year): | 35.64% |
Latest ImmunoPrecise Antibodies Ltd. News
IPA Breaking Stock News: Dive into IPA Ticker-Specific Updates for Smart Investing
Business Wire
5 days ago
$20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies
Business Wire
14 days ago
ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation
Business Wire
21 days ago
ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology
Business Wire
a month ago
ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024
Business Wire
a month ago
ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design
GuruFocus.com
a month ago
ImmunoPrecise Antibodies Ltd (IPA) Q4 2024 Earnings Call Highlights: Record Revenue Growth Amid ...
Business Wire
2 months ago
ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus
Business Wire
2 months ago
ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments
Compare IPA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IPA ImmunoPrecise Antibodies Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.